Riskpilot← Back to searchSign inGet full accessARTHREX NORWAY AS
ASActiveOrg 915459528O.H. Bangs Vei 70, 1363 HøvikWholesale of pharmaceutical and medical goods · NACE 4646Est. 201527 employees
Revenue 2025
NOK 121,7M
+14% vs 2024
EBITDA margin
7.8%
+178% vs 2024
Equity ratio
57.4%
Financial strength
Net profit 2025
NOK 2,8M
+425% vs 2024
| Revenue | NOK 121,7M | +14% |
| EBITDA | NOK 9,5M | +178% |
| Net profit | NOK 2,8M | +425% |
| Total assets | NOK 41,9M | +1% |
| Equity | NOK 24M | +13% |
| Employees | 27 | — |
Legal name
ARTHREX NORWAY AS
Org number
915459528
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juni 2015
Share capital
NOK 16 300 000
Employees
27 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Distribusjon av medisinsk utstyr samt det som naturlig står i forbindelse med dette.
Address
O.H. Bangs Vei 70, 1363 Høvik
Phone
+4767519400
Email
lisa.gardiner@arthrex.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 81 564 | 81 044 | 95 317 | 106 504 | 121 700 |
| Staff expenses | −15 465 | −17 682 | −21 344 | −25 816 | −28 401 |
| EBITDA | 13 465 | 9 975 | 8 116 | 3 429 | 9 520 |
| Depreciation & amort. | −4 123 | −3 707 | −3 264 | −4 112 | −5 119 |
| EBIT | 9 343 | 6 267 | 4 853 | −683 | 4 401 |
| Net financials | 1 409 | −287 | −1 825 | −53 | −498 |
| Profit before tax | 10 752 | 5 980 | 3 028 | −736 | 3 903 |
| Tax | 2 370 | 1 268 | 386 | 141 | 1 054 |
| Net profit | 8 382 | 4 712 | 2 642 | −877 | 2 848 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 31 391 | 33 446 | 40 747 | 41 645 | 41 866 |
| Equity | 16 856 | 19 408 | 22 050 | 21 172 | 24 021 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 14 535 | 14 038 | 18 697 | 20 473 | 17 845 |
| Total debt | 14 535 | 14 038 | 18 697 | 20 473 | 17 845 |
EBITDA margin
7.8%
This company
15.8%
Market median
-51% vs market
20212025
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20212025
Return on equity
11.9%
This company
18.4%
Market median
+35% vs market
20212025
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20212025
Asset turnover
2.91×
This company
1.12×
Market median
+160% vs market
20212025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BC Contact Person | Contact Person | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2023 | |
| Former (2) | ||
| Chairman | 2020 – 2023 | |
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Arthrex Gmbh | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ARTHREX NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bente Carlsen | Contact Person | 0 companies |
| Stefan Hans Jozef Krupp | Chairman | 0 companies |
| Geert Jos Marcel Onan | Board of Directors | 0 companies |
| Erik Søfren Røer Poulsson | Board of Directors | 0 companies |
| Torgeir Erlandsen | Chairman | 0 companies |